Kraematon Investment Advisors, Inc Johnson & Johnson Transaction History

Kraematon Investment Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$155.22 - $162.74 $197,750 - $207,330	1,274 New	1,274 $201,000
Q3 2023 Nov 01, 2023	BUY	$155.75 - $174.48 $155 - $174	1 Added 0.07%	1,472 $229,000
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $5,402 - $5,813	35 Added 2.44%	1,471 $243,000
Q1 2023 Apr 12, 2023	SELL	$151.05 - $180.26 $5,286 - $6,309	-35 Reduced 2.38%	1,436 $222,000
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $160 - $179	1 Added 0.07%	1,471 $259,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $5,323 - $5,924	-33 Reduced 2.2%	1,470 $240,000
Q2 2022 Jul 27, 2022	BUY	$168.19 - $186.01 $336 - $372	2 Added 0.13%	1,503 $267,000
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $158 - $179	1 Added 0.07%	1,501 $266,000
Q4 2021 Feb 16, 2022	BUY	$155.93 - $173.01 $233,895 - $259,515	1,500 New	1,500 $257,000

4,227

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Kraematon Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Kraematon Investment Advisors, Inc with notifications on news.